Go to:
Logótipo
You are here: Start > Publications > View > Sulfonamide a Valid Scaffold for Antioxidant Drug Development
B-On anuncia condições para publicação em Acesso Aberto no triénio 2025-2027
Publication

Sulfonamide a Valid Scaffold for Antioxidant Drug Development

Title
Sulfonamide a Valid Scaffold for Antioxidant Drug Development
Type
Another Publication in an International Scientific Journal
Year
2023
Authors
Fernanda Borges
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Saso, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Egbujor, MC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Garrido, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
Vol. 20
Pages: 190-209
ISSN: 1570-193X
Publisher: Bentham Science
Other information
Authenticus ID: P-00X-4T1
Abstract (EN): Like the well-known sulfa drugs, Sulfonamides are ascribed to a myriad of biological activities, including antioxidant activity. In fact, several tertiary sulfonamides, particularly N, N-disubstituted analogues, are recognized as antioxidants that can prevent or minimize oxidative damage associated with several oxidative-stress-related diseases. The structural diversity of this class of compounds paved the way for drug discovery programs aimed at finding therapeutic agents. Attributes such as low-cost synthetic procedures, easy accessibility of reagents, and a broad spectrum of biological activities made sulfonamides and derivatives excellent candidates for synthesizing chemical libraries with structural diversity. Sulfonamide-based drugs are most of the sulfur-containing drugs approved by the United States Food and Drug Administration (FDA). Although sulfonamide derivatives have been extensively exploited as antibacterial agents, their therapeutic potential as antioxidants is relatively underexplored despite the prevalence of oxidative stress-mediated diseases and the urgent need for new and more effective antioxidant drugs. Some sulfonamide derivatives were shown to activate the nuclear factor erythroid 2-related factor 2 (Nrf2), the main regulator of the endogenous antioxidant response, a critical process used by cells in response to oxidative stress. The antioxidant role of sulfonamides and derivatives as Nrf2 activators is also reviewed. The antioxidant mechanism of action of sulfonamides has not been fully clarified, but as they have antioxidant properties, it is a subject worthy of in-depth study. The present review is focused on sulfonamides and derivatives as potential antioxidants along the period 2013-2021 and intends to stimulate research in the area.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 20
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Recent Developments and Challenges in the Application of Fungal Laccase for the Biodegradation of Textile Dye Pollutants (2024)
Another Publication in an International Scientific Journal
F.F. Magalhães; A.F.S. Pereira; Raquel O. Cristóvão; R.A.M. Barros; Joaquim Luís Faria; Claudia G Silva; M.G. Freire; A.P.M. Tavares
Recommend this page Top
Copyright 1996-2025 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2025-06-26 at 19:46:21 | Acceptable Use Policy | Data Protection Policy | Complaint Portal